4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-022521
PRESIDENT AND CEO gave up 16,959 shares (to pay taxes)
- PRESIDENT AND CEO acquired 69,641 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise | +6,758 | 5,268,493 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Shares withheld for taxes | −1,646 | $4.06 | $6,683 | 5,266,847 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise | +11,781 | 5,278,628 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Shares withheld for taxes | −2,869 | $4.06 | $11,648 | 5,275,759 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise | +22,100 | 5,297,859 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Shares withheld for taxes | −5,382 | $4.06 | $21,851 | 5,292,477 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise | +29,002 | 5,321,479 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Shares withheld for taxes | −7,062 | $4.06 | $28,672 | 5,314,417 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise · Restricted Stock Units | −6,758 | 11,272 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise · Restricted Stock Units | −11,781 | 74,618 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise · Restricted Stock Units | −22,100 | 228,373 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-08-18 | Option exercise · Restricted Stock Units | −29,002 | 415,701 | D | ||
Loading xslF345X05/form4-08202025_090803.xml…